It is remarkable that H3Y41 phosphorylation requires a hyperactive JAK2, implying that the activation of different pathways with different JAK2 effectors and different target genes is involved in the pathogenesis of MPN. Here, JAK2 is linked to myeloproliferative neoplasm.